APA (7th ed.) Citation

Elio Novembre, Mariangela Tosca, Carlo Caffarelli, Mauro Calvani, Fabio Cardinale, Riccardo Castagnoli, . . . Gian Luigi Marseglia. (2022). Management of BNT162b2 mRNA COVID-19 vaccine in children aged 5-11 years with allergies, asthma, and immunodeficiency: Consensus of the Italian Society of Pediatric Allergy and Immunology (SIAIP). BMC.

Chicago Style (17th ed.) Citation

Elio Novembre, et al. Management of BNT162b2 MRNA COVID-19 Vaccine in Children Aged 5-11 years with Allergies, Asthma, and Immunodeficiency: Consensus of the Italian Society of Pediatric Allergy and Immunology (SIAIP). BMC, 2022.

MLA (9th ed.) Citation

Elio Novembre, et al. Management of BNT162b2 MRNA COVID-19 Vaccine in Children Aged 5-11 years with Allergies, Asthma, and Immunodeficiency: Consensus of the Italian Society of Pediatric Allergy and Immunology (SIAIP). BMC, 2022.